1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
14.47 -0.01 (-0.07%)
80.01% Fall from 52W High
379.5K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Keros Therapeutics Inc is on 07 Aug 2025 for the purpose of Keros Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
37.8 / 100
Momentum Score
Technically Neutral
51.7 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
24
1Yr Price target upside is 66%
9 analysts

11

S

11

W

5

O

0

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..